Living proof and the pseudoscience of alternative cancer treatments
- PMID: 18302909
- PMCID: PMC2630257
Living proof and the pseudoscience of alternative cancer treatments
Abstract
Michael Gearin-Tosh was an English professor at Oxford University who was diagnosed with multiple myeloma in 1994. He rejected conventional chemotherapeutic approaches and turned to a variety of alternative cancer treatments, particularly those involving nutritional supplements and dietary change. In 2002, Dr. Gearin-Tosh published a book, Living Proof: A Medical Mutiny, recounting his experiences. The book gained significant public and media attention. One chapter was written by Carmen Wheatley, an advocate of alternative cancer treatments. In distinction to Dr. Gearin-Tosh's personal story, Dr. Wheatley makes general claims about cancer treatment that are supposedly based on the research literature. This appears to provide scientific validation for a highly unconventional program of cancer care. However, the scientific case made for alternative cancer treatments in Living Proof does not bear serious examination. There are numerous inaccuracies, omissions, and misrepresentations. Many important claims are either entirely unsubstantiated or not supported by the literature cited. In conclusion, a highly publicized book gives the impression that alternative cancer treatments are supported by scientific research. It also suggests that little progress has been made in the conventional treatment of myeloma. This is highly misleading and may lead to cancer patients rejecting effective treatments.
Similar articles
-
Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!Hell J Nucl Med. 2018 Jan-Apr;21(1):85-87. doi: 10.1967/s002449910713. Epub 2018 Mar 20. Hell J Nucl Med. 2018. PMID: 29550853
-
In Response To: Professor Cassileth's manuscript on "Alternative and Complementary Cancer Treatments," Featured in The Oncologist 1996;1:173-179.Oncologist. 1996;1(5):324-325. Oncologist. 1996. PMID: 10388010
-
The breast cancer prevention diet by Dr. Bob Arnot: unscientific and deceptive--a disservice to American women.J Health Commun. 1999 Jul-Sep;4(3):235-48. doi: 10.1080/108107399126940. J Health Commun. 1999. PMID: 10977291 Review.
-
How useful are unconventional cancer treatments?Eur J Cancer. 1999 Oct;35(11):1608-13. doi: 10.1016/s0959-8049(99)00198-7. Eur J Cancer. 1999. PMID: 10673970 Review.
-
[Do we need an alternative medicine?].Fortschr Kieferorthop. 1992 Feb;53(1):61-6. doi: 10.1007/BF02165147. Fortschr Kieferorthop. 1992. PMID: 1551630 Review. German.
Cited by
-
Medicinal mushroom Phellinus linteus as an alternative cancer therapy.Exp Ther Med. 2010 May;1(3):407-411. doi: 10.3892/etm_00000063. Epub 2010 May 1. Exp Ther Med. 2010. PMID: 22993555 Free PMC article.
References
-
- Gearin-Tosh M. Living Proof: a medical mutiny. New York: Scribner; 2002.
-
- Hildenbrand GL, Hildenbrand LC, Bradford K, Cavin SW. Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review. Alternative Therapies in Health and Medicine. 1995;1:29–37. - PubMed
-
- Zollman C, Rees R. Disputes conclusions in Hildenbrand study [letter] Alternative Therapies in Health & Medicine. 1917;2:14–15. - PubMed
-
- Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. New England Journal of Medicine. 1979;301:687–690. - PubMed
-
- Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985;312:137–141. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials